The Centre has brought amendments to rationalise the royalty rates and successfully auctioned 24 critical mineral blocks in four tranches an effort to drive th ...

Plus Therapeutics presents ReSPECT-LM phase 1 trial data for breast cancer patients with leptomeningeal metastases: Austin, Texas Friday, December 20, 2024, 18:00 Hrs [IST] Plus T ...

Plus Therapeutics (PSTV) presented data updating the progress of its ReSPECT-LM Phase 1 clinical trial of Rhenium Obisbemeda in leptomeningeal disease with a specific focus on breast cancer patients.

Detailed price information for Bell Copper Corp (BCUFF) from The Globe and Mail including charting and trades.

Heilongjiang Provincial Key Laboratory of CO2 Resource Utilization and Energy Catalytic Materials, School of Material Science and Chemical Engineering, Harbin University of Science and Technology, ...

This MSA secures a reliable supply of cGMP Re-186, the radioisotope used in Plus Therapeutics’ lead radiotherapeutic candidate Rhenium (186 Re) Obisbemeda. “This continuing agreement with ...